TCR-T therapy(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)

N/A

Report date: 2022/07/08 22:10:06

Base Information

Drug NameTCR-T therapy(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionT lymphocyte replacementsKRAS G12V modulatorsKRAS G12D modulators
TargetsKRAS G12VKRAS G12D
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSun Yat-Sen Memorial Hospital Of Sun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen Memorial Hospital Of Sun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A